JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 2009; 109:194-198
© 2009 International Anesthesia Research Society
doi: 10.1213/ane.0b013e3181a3ea3a
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Girard, F.
Right arrow Articles by Ruel, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Girard, F.
Right arrow Articles by Ruel, M.
Related Collections
Right arrow Neuroanesthesia
Right arrow Physiology
Right arrow Clinical Pharmacology
Right arrow Pharmacology


NEUROSURGICAL ANESTHESIOLOGY AND NEUROSCIENCE

The Effect of Sedation on Intracranial Pressure in Patients with an Intracranial Space-Occupying Lesion: Remifentanil Versus Propofol

Francois Girard, MD, FRCPC*, Robert Moumdjian, MD, FRCSC{dagger}, Daniel Boudreault, MD, FRCPC*, Philippe Chouinard, MD, FRCPC*, Alain Bouthilier, MD, FRCSC{dagger}, and Monique Ruel, RN*

From the *Department of Anesthesiology, and {dagger}Neurosurgery Division, Centre Hospitalier de l’Université de Montréal, Hôpital Notre-Dame, Montreal, Canada.

Address correspondence to François Girard, MD, FRCPC, Department of Anesthesiology, CHUM, Hôpital Notre-Dame, 1560 Sherbrooke East, Montreal, Canada, H2L 4M1. Address e-mail to francois.girard.chum{at}ssss.gouv.qc.ca.

Abstract

BACKGROUND: In this study, we compared the effect of light sedation with remifentanil versus propofol on intracranial (ICP) and cerebral perfusion pressure (CPP) of patients undergoing stereotactic brain tumor biopsy under regional anesthesia.

METHODS: This was a prospective, open-label, randomized, and controlled study. Forty patients undergoing stereotactic brain tumor biopsy under regional anesthesia were randomized into two groups to receive remifentanil or propofol titrated to a level of four on the modified Assessment of Alertness/Sedation Scale. ICP was measured via the biopsy needle.

RESULTS: At the targeted level of sedation, the rates of infusion for remifentanil and propofol were, respectively, 4.2 ± 1.8 µg · kg–1 · h–1 and 4.3 ± 2.5 mg · kg–1 · h–1. At the time of ICP measurement, patients in the remifentanil group had a slower respiratory rate (11/min ± 3 vs 15 per min ± 3, P = 0.0001) and a higher Pco2 (48.3 ± 6.2 mm Hg vs 43.1 ± 5.5 mm Hg, P = 0.009) than patients in the propofol group. The mean was similar for both groups, 19.0 ± 11.9 mm Hg vs 16.4 ± 11.1 mm Hg for remifentanil and propofol, respectively (P = 0.48). Higher mean arterial blood pressure in the remifentanil group (101.1 ± 13.7 mm Hg vs 85.8 ± 12.7 mm Hg, P = 0.0008) resulted in a higher CPP than the propofol group: 82.0 ± 19.0 mm Hg vs 69.5 ± 17.0 ± 19.0 mm Hg (P = 0.03).

CONCLUSION: Light sedation with remifentanil does not result in a higher ICP than propofol in patients undergoing stereotactic brain tumor biopsy. CPP might be better preserved with remifentanil.







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2009 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2009 by the International Anesthesia Research Society.